Eyenovia on Thursday said it has signed a non-binding letter of intent to combine with clinical-stage pharmaceutical company Betaliq in an all-stock reverse merger. Eyenovia said Betaliq investors ...
Carisma Therapeutics had already laid off 95% of its team earlier this year. | After Carisma Therapeutics laid off 95% of its team earlier this year, a Hail Mary merger proposal with another biotech ...
The bowling-and-bocce restaurant chain went public in late 2023. By this year it sought Chapter 11 bankruptcy and closed ...
FREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), an emerging leader in the development of non-opioid pain ...
STAMFORD, Conn., April 14, 2025 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that its Board of Directors (the “Board”) has approved a 1-for-3 reverse ...
TipRanks on MSN
Asset Entities says shareholders approve merger with Strive
Asset Entities (ASST) on Tuesday announced that its stockholders have voted to approve the previously announced merger with Strive Enterprises, ...
Stamford-based Cara Therapeutics Inc. announced Monday that its board of directors has approved a 1-for-3 reverse common stock stock split. Cara’s common stock, which trades on the Nasdaq stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback